Aethlon Medical, Inc. (AEMD) financial statements (2020 and earlier)
Company profile
| Business Address |
9635 GRANITE RIDGE DRIVE, SUITE 100 SAN DIEGO, CA 92123 |
| State of Incorp. | NV |
| Fiscal Year End | March 31 |
| SIC | 3826 - Laboratory Analytical Instruments (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in millions)
| 9/30/2019 TTM | 3/31/2019 | 3/31/2018 | 3/31/2017 | 3/31/2016 | 3/31/2015 | 3/31/2014 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 1 | 4 | 7 | 2 | 2 | 1 | 1 | ||
| Cash and cash equivalents | 1 | 4 | 7 | 2 | 2 | 1 | 1 | ||
| Receivables | 0 | 0 | 0 | 0 | |||||
| Other undisclosed current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Total current assets: | 1 | 4 | 7 | 2 | 2 | 1 | 1 | ||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 0 | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Property, plant and equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Intangible assets, net (including goodwill) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Intangible assets, net (excluding goodwill) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Deposits noncurrent assets | 0 | 0 | 0 | 0 | |||||
| Other noncurrent assets | 0 | ||||||||
| Other undisclosed noncurrent assets | 0 | 0 | |||||||
| Total noncurrent assets: | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| TOTAL ASSETS: | 1 | 4 | 7 | 2 | 3 | 1 | 2 | ||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 1 | 0 | 0 | 0 | 0 | 0 | 2 | ||
| Accounts payable | 1 | 0 | 0 | 0 | 0 | 0 | 1 | ||
| Interest and dividends payable | 0 | 1 | |||||||
| Deferred revenue | 0 | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Debt | 0 | 1 | 0 | ||||||
| Derivative instruments and hedges, liabilities | 11 | ||||||||
| Due to related parties | 0 | 0 | 0 | 0 | 0 | 0 | 1 | ||
| Other liabilities | 0 | 1 | 0 | 0 | 0 | 0 | 2 | ||
| Other undisclosed current liabilities | (0) | 0 | |||||||
| Total current liabilities: | 1 | 2 | 0 | 1 | 1 | 1 | 16 | ||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 0 | 1 | 1 | 1 | 0 | 1 | |||
| Long-term debt, excluding current maturities | 1 | 1 | 1 | 0 | 1 | ||||
| Operating lease, liability | 0 | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Total noncurrent liabilities: | 0 | 1 | 1 | 1 | 0 | 1 | |||
| Total liabilities: | 1 | 2 | 1 | 1 | 1 | 1 | 16 | ||
| Stockholders' equity | |||||||||
| Stockholders' equity attributable to parent | 0 | 2 | 6 | 1 | 2 | 1 | (15) | ||
| Common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Additional paid in capital | 110 | 108 | 106 | 94 | 88 | 82 | 60 | ||
| Accumulated deficit | (109) | (106) | (99) | (94) | (87) | (82) | (75) | ||
| Stockholders' equity attributable to noncontrolling interest | (0) | (0) | (0) | (0) | (0) | 0 | 0 | ||
| Total stockholders' equity: | 0 | 2 | 6 | 1 | 2 | 1 | (15) | ||
| TOTAL LIABILITIES AND EQUITY: | 1 | 4 | 7 | 2 | 3 | 1 | 2 | ||
Income statement (P&L) ($ in millions)
| 9/30/2019 TTM | 3/31/2019 | 3/31/2018 | 3/31/2017 | 3/31/2016 | 3/31/2015 | 3/31/2014 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue, net | ✕ | ✕ | 0 | 0 | 1 | 1 | 1 | |
| Other income | 0 | ✕ | ||||||
| Gross profit: | 0 | 0 | 0 | 0 | 1 | 1 | 2 | |
| Operating expenses | (7) | (6) | (5) | (6) | (5) | (5) | (5) | |
| Other operating expense, net (Other Expenses) | (3) | (0) | ||||||
| Other undisclosed operating income | 3 | 0 | ||||||
| Operating loss: | (7) | (6) | (5) | (6) | (4) | (4) | (3) | |
| Nonoperating income | 10 | |||||||
| Interest and debt expense | (0) | (0) | (0) | (0) | (1) | (0) | 1 | |
| Income (loss) before gain (loss) on sale of properties: | (7) | (6) | (5) | (6) | (5) | (4) | 9 | |
| Other undisclosed net loss | (0) | (1) | (1) | (3) | (22) | |||
| Net loss: | (7) | (6) | (6) | (7) | (5) | (7) | (13) | |
| Net income attributable to noncontrolling interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Net loss available to common stockholders, diluted: | (7) | (6) | (6) | (7) | (5) | (7) | (13) | |
Comprehensive Income ($ in millions)
| 9/30/2019 TTM | 3/31/2019 | 3/31/2018 | 3/31/2017 | 3/31/2016 | 3/31/2015 | 3/31/2014 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (7) | (6) | (6) | (7) | (5) | (7) | (13) | |
| Comprehensive loss: | (7) | (6) | (6) | (7) | (5) | (7) | (13) | |
| Comprehensive income, net of tax, attributable to noncontrolling interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Comprehensive loss, net of tax, attributable to parent: | (7) | (6) | (6) | (7) | (5) | (7) | (13) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.